News Archive
-
New VIDO Vaccine Development Centre supports vaccine innovation protecting Canadians, animals
USask's Vaccine and Infectious Disease Organization has completed the construction of its Vaccine Development Centre, strengthening and expanding Canada’s domestic biomanufacturing capacity.
-
VIDO: Saskatchewan’s gift to global health
The opening of its new Vaccine Development Centre advances VIDO’s position as Canada’s Centre for Pandemic Research.
-
USask hosts the Prime Minister of Canada
Prime Minister Justin Trudeau paid tribute to the contributions the University of Saskatchewan has made to scientific discovery, as he wrapped up his visit to campus on Wednesday.
-
A new opportunity to develop livestock and human vaccine in Saskatchewan: SARM supports VIDO‘s effort to strengthen the response to infectious disease
The Saskatchewan Association of Rural Municipalities Board of Director’s met with VIDO in January, to discuss the ways rural municipalities can support and strengthen the world’s response to infectious diseases.
-
Developing oral vaccine for chronic wasting disease goal of funding research
Prion disease poses significant risk to wildlife, but research into developing vaccine cause for optimism.
-
Investments in USask livestock research fuels innovation, protects animal health
University of Saskatchewan (USask) researchers have been awarded $4.2 million to develop livestock-related innovations that range from improving forage feed to advancing work on vaccines to tackle the global spread of African swine fever (ASF).